Weight loss is the obvious effect of GLP-1 receptor agonists. I am more interested in the emerging picture around reward circuitry, habit formation and compulsive behaviour.

The signals are early: less interest in alcohol, quieter “food noise” and weaker compulsive patterns in other domains. Lilly is running trials in smoking cessation and alcohol use disorder; people also report losing interest in doomscrolling, gambling and impulse shopping. If these effects hold up, GLP-1s are doing something more general than suppressing appetite.

You’re outgunned

I borrowed this framing from Performative Bafflement, who put it better than I could: before GLP-1s, we asked people to white-knuckle their way past Skinner boxes that ten thousand PhDs had spent years optimising against them.

The asymmetry is absurd: large consumer companies build fine-grained models of behaviour and motivation, then use them to find and pull whatever neurological hooks will alter behaviour at scale. The result is a collection of biologically grounded superstimuli: junk food engineered to bypass satiety signals, online gambling, infinite scroll and ragebait. Phone time has reportedly grown from 2–3 hours a day in 2014 to 7–9 hours among Gen Z.

To a first approximation, everyone is outgunned. Opting out only gets you so far; you can avoid junk food, social media and clickbait, yet still live among people and institutions shaped by the same machinery.

Revealed priorities

Revealed priorities means treating behaviour as evidence. The way you spend your time shows what you are prioritising, regardless of what you say or wish you valued.

GLP-1s can leave those values alone while increasing your capacity to act on them. When the immediate pull of food, alcohol or doomscrolling weakens, there is room to choose. Ragebait and endless scroll begin to look like what they are: sad, dark little reward dispensers that were never going to lead anywhere.

Improvements in weight, health markers or habits can create a sense of agency; wasted hours, including the minutes of distraction scattered across a day, then become more obviously expensive. You start protecting your time because you can finally feel its opportunity cost.

This is how the drug can bootstrap a positive path: enough distance from the loop for deeper priorities to become behaviour.

The seatbelt analogy

A seatbelt does not make you a better driver or change how much you value safety. It limits how much damage a dangerous environment can do.

GLP-1s work in much the same way. They do not manufacture willpower or virtue; they reduce the pull of an environment deliberately engineered to exploit neurological vulnerabilities.

We do not moralise about seatbelts. We should not moralise about this either.

The uncomfortable implication

If GLP-1s reveal what people actually want to prioritise when the reward noise is turned down, what does that say about all the time we have spent judging people for their “choices”?

Perhaps much of what we call weakness of will is losing a fight you were never equipped to win. Someone doomscrolling at 2 am may be losing to a system designed for exactly that outcome.

Moralising produces the instruction to try harder; the revealed priorities frame asks whether effort was ever the binding constraint. If the fight is asymmetric, GLP-1s may be the first tool that changes the odds.